查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1352780

全球個人化醫療市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

Global Personalized Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球個人化醫療市場需求預計將從 2022 年的 6,380.2 億美元增至 2030 年的近 1,2092.1 億美元，2023-2030 年研究期間複合年成長率為 8.32%。

個人化醫療著重於透過收集有關個人遺傳學的資訊來進行個人化治療。它透過識別個體特有的某些基因並根據它們制定治療方案，徹底改變了醫學領域。它還有助於找出使人容易患某些疾病的基因，並嘗試預防這些疾病。它透過提供有關惡性腫瘤的基本資訊來規劃治療過程或檢查患者對治療的反應程度，特別有助於治療癌症。這是一種客製化的治療方法，可以按時為患者提供正確的治療。個人化醫療有助於改善患者的生活品質並顯著降低治療成本。

市場動態：

在研究期間，個人化醫療市場呈現出良好的成長動能。人們越來越關注生物標記或基因在疾病診斷、治療和預測中的作用，以促進個人化醫療的發展，這促進了市場的成長。市場成長也歸因於癌症和自體免疫等疾病的數量不斷增加，與其他療法相比，個人化醫療在治療這些疾病方面非常有效。藥物基因組學領域或研究人的 DNA 如何影響其對藥物的反應方式的進展將為開發針對患者的藥物創造有利的氛圍。這將推動個人化藥物市場的發展。降低用藥錯誤和有害藥物反應的風險、快速見效以及這些藥物的客製化效果將促進該領域的研究和開發，並為個人化藥物創造市場收入。政府對這些藥物的彈性政策將為市場創造新的成長機會。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球個人化醫療市場的每個細分市場進行了包容性評估。個人化醫療產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲個人化醫療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。個人化醫療市場的主要參與者包括 Illumina Inc.、GE Healthcare、Danaher Corporation (Cepheid Inc.)、Abbott、QIAGEN、Exact Sciences Corporation、ASURAGEN INC.、Biogen、Dako A/S、Exagen Inc.、Precision Biologics、 Celera Diagnostics LLC、Decode Genetics Inc.、Genelex、IBM、Genentech Inc.、23andME Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：個人化醫療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球個人化醫療市場分析：依產品分類

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 個人化醫學診斷（基因檢測、DTC 診斷、深奧實驗室服務、深奧實驗室檢驗）
  • 個人化醫療治療（製藥、基因組醫學、醫療器材）
  • 個人化醫療（遠距醫療、健康資訊科技）
  • 個人化營養與健康（零售營養、補充與替代醫學）

第 7 章：全球個人化醫療市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：個人化醫療公司的競爭格局

  • 個性化醫療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Illumina Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GE Healthcare
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Danaher Corporation (Cepheid Inc.)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • QIAGEN
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Exact Sciences Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ASURAGEN INC.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biogen
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dako A/S
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Exagen Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Precision Biologics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Celera Diagnostics LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Decode Genetics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Genelex
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IBM
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Genentech Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • 23andME Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11219103

The global demand for Personalized Medicine Market is presumed to reach the market size of nearly USD 1209.21 BN by 2030 from USD 638.02 BN in 2022 with a CAGR of 8.32% under the study period 2023 - 2030.

Personalized Medicine focuses on individualized treatment by gathering information about a person's genetics. It has revolutionized the field of Medicine by identifying certain genes specific to an individual and planning treatment based on them. It also helps to find out genes that make a person vulnerable to certain diseases and attempts to prevent them. It especially helps in treating cancer by giving essential information about a malignant tumour to plan the course of treatment or check how well the patient responds to the treatment. This is a customized treatment method to offer the correct treatment to the patient on time. Personalized Medicine helps improve patient's quality of life and significantly reduces treatment costs.

MARKET DYNAMICS:

The personalized medicine market shows favourable growth during the study period. The growing focus on the role of the biomarker or gene in the diagnosis, treatment, and prediction of diseases for the development of personalized Medicine has contributed to the market's growth. The market growth is also attributed to the fact that the number of diseases like cancer and autoimmune is increasing, and personalized Medicine is highly effective in treating them compared to other therapies. The progress in the field of pharmacogenomics or the study of how a person's DNA affects his way of responding to medications will create a favorable atmosphere for developing patient-specific drugs. This will boost the market for personalized medicines. Reduced risk for medication errors and harmful drug reactions, fast results, and customized effects of these medicines will facilitate the research and development in this field and generate market revenue for personalized medicines. Flexible government policies toward these medicines will create new growth opportunities in the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of personalized medicine. The growth and trends of personalized medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the personalized medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Personalized Medicine Diagnostics (Genetic Testing, Dtc Diagnostics, Esoteric Lab Services, Esoteric Lab Tests)
  • Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices)
  • Personalized Medical Care (Telemedicine, Health Information Technology)
  • Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Personalized Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the personalized medicine market include Illumina Inc., GE Healthcare, Danaher Corporation (Cepheid Inc.), Abbott, QIAGEN, Exact Sciences Corporation, ASURAGEN INC., Biogen, Dako A/S, Exagen Inc., Precision Biologics, Celera Diagnostics LLC, Decode Genetics Inc., Genelex, IBM, Genentech Inc., 23andME Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PERSONALIZED MEDICINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Historic and Forecast Sales by Regions
  • 6.5 Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Historic and Forecast Sales by Regions
  • 6.6 Personalized Medical Care (Telemedicine, Health Information Technology) Historic and Forecast Sales by Regions
  • 6.7 Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Historic and Forecast Sales by Regions

7 . GLOBAL PERSONALIZED MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PERSONALIZED MEDICINE COMPANIES

  • 8.1. Personalized Medicine Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PERSONALIZED MEDICINE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Illumina Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. GE Healthcare
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Danaher Corporation (Cepheid Inc.)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Abbott
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. QIAGEN
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Exact Sciences Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. ASURAGEN INC.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Biogen
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Dako A/S
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Exagen Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Precision Biologics
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Celera Diagnostics LLC
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Decode Genetics Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Genelex
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. IBM
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Genentech Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. 23andME Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Market Sales by Geography (USD MN)
  • Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Market Sales by Geography (USD MN)
  • Personalized Medical Care (Telemedicine, Health Information Technology) Market Sales by Geography (USD MN)
  • Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Market Sales by Geography (USD MN)
  • Global Personalized Medicine Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Personalized Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Personalized Medicine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests) Market Sales by Geography (USD MN)
  • Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices) Market Sales by Geography (USD MN)
  • Personalized Medical Care (Telemedicine, Health Information Technology) Market Sales by Geography (USD MN)
  • Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine) Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.